Osteogenesis imperfecta is an inherited disorder characterized by increased bone fragility, fractures, and osteoporosis, and most cases are caused by mutations affecting the type I collagen genes. Here, we describe a new mouse model for Osteogenesis imperfecta termed Aga2 (abnormal gait 2) that was isolated from the Munich N-ethyl-N-nitrosourea mutagenesis program and exhibited phenotypic variability, including reduced bone mass, multiple fractures, and early lethality. The causal gene was mapped to Chromosome 11 by linkage analysis, and a C-terminal frameshift mutation was identified in the Col1a1 (procollagen type I, alpha 1) gene as the cause of the disorder. Aga2 heterozygous animals had markedly increased bone turnover and a disrupted native collagen network. Further studies showed that abnormal proalpha1(I) chains accumulated intracellularly in Aga2/+ dermal fibroblasts and were poorly secreted extracellularly. This was associated with the induction of an endoplasmic reticulum stress-specific unfolded protein response involving upregulation of BiP, Hsp47, and Gadd153 with caspases-12 and -3 activation and apoptosis of osteoblasts both in vitro and in vivo. These studies resulted in the identification of a new model for Osteogenesis imperfecta, and identified a role for intracellular modulation of the endoplasmic reticulum stress-associated unfolded protein response machinery toward osteoblast apoptosis during the pathogenesis of disease.
Impact Factor
Scopus SNIP
Web of Science Times Cited
Scopus Cited By
Altmetric
8.721
0.880
105
112
Tags
Annotations
Special Publikation
Hide on homepage
Publication typeArticle: Journal article
Document typeScientific Article
Thesis type
Editors
KeywordsCARBOXYL-TERMINAL PROPEPTIDE; ENDOPLASMIC-RETICULUM STRESS; I COLLAGEN; DIFFERENTIAL EXPRESSION; BONE HISTOMORPHOMETRY; PRO-ALPHA-1(I) CHAIN; TRANSGENIC MICE; BINDING SITES; MURINE MODEL; LETHAL
POF-Topic(s)30201 - Metabolic Health 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease 30205 - Bioengineering and Digital Health
Research field(s)Genetics and Epidemiology Enabling and Novel Technologies